Rui-Lan Huang
Rui-Lan Huang
Dpt. of OB/GYN, School of Medicine, College of Medicine and Dpt. of OB/GYN, Shuang Ho Hospital, TMU
Verified email at
Cited by
Cited by
Identification of novel DNA methylation markers in cervical cancer
HC Lai, YW Lin, THM Huang, P Yan, RL Huang, HC Wang, J Liu, ...
International journal of cancer 123 (1), 161-167, 2008
Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface
MKS Tang, PYK Yue, PP Ip, RL Huang, HC Lai, ANY Cheung, KY Tse, ...
Nature communications 9 (1), 2270, 2018
CpG island shore methylation regulates caveolin-1 expression in breast cancer
X Rao, J Evans, H Chae, J Pilrose, S Kim, P Yan, RL Huang, HC Lai, ...
Oncogene 32 (38), 4519-4528, 2013
Downregulation of miR‐29 contributes to cisplatin resistance of ovarian cancer cells
PN Yu, MD Yan, HC Lai, RL Huang, YC Chou, WC Lin, LT Yeh, YW Lin
International journal of cancer 134 (3), 542-551, 2014
Growth inhibition of ovarian tumor–initiating cells by niclosamide
YT Yo, YW Lin, YC Wang, C Balch, RL Huang, MWY Chan, HK Sytwu, ...
Molecular cancer therapeutics 11 (8), 1703-1712, 2012
Methylomics analysis identifies epigenetically silenced genes and implies an activation of β‐catenin signaling in cervical cancer
YC Chen, RL Huang, YK Huang, YP Liao, PH Su, HC Wang, CC Chang, ...
International journal of cancer 135 (1), 117-127, 2014
Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse
HC Lai, YW Lin, RL Huang, MT Chung, HC Wang, YP Liao, PH Su, YL Liu, ...
Cancer 116 (18), 4266-4274, 2010
Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients
JL Chou, RL Huang, J Shay, LY Chen, SJ Lin, PS Yan, WT Chao, YH Lai, ...
Clinical epigenetics 7, 1-11, 2015
Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasms
RL Huang, CC Chang, PH Su, YC Chen, YP Liao, HC Wang, YT Yo, ...
PloS one 7 (7), e41060, 2012
Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer
PH Su, YW Lin, RL Huang, YP Liao, HY Lee, HC Wang, TK Chao, ...
Oncogene 32 (1), 15-26, 2013
Integrated epigenomics analysis reveals a DNA methylation panel for endometrial cancer detection using cervical scrapings
RL Huang, PH Su, YP Liao, TI Wu, YT Hsu, WY Lin, HC Wang, YJ Weng, ...
Clinical Cancer Research, clincanres. 0863.2016, 2017
Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
CK Lin, MY Bai, TM Hu, YC Wang, TK Chao, SJ Weng, RL Huang, PH Su, ...
Oncotarget 7 (8), 8993, 2016
Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients
YP Liao, LY Chen, RL Huang, PH Su, MWY Chan, CC Chang, MH Yu, ...
Human molecular genetics 23 (7), 1894-1906, 2014
High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma
CC Chang, RL Huang, HC Wang, YP Liao, MH Yu, HC Lai
Int J Gynecol Cancer 24 (2), 201-209, 2014
Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers
RL Huang, F Gu, NB Kirma, J Ruan, CL Chen, HC Wang, YP Liao, ...
Epigenetics 8 (6), 624-634, 2013
The role of GRHL2 and epigenetic remodeling in epithelial–mesenchymal plasticity in ovarian cancer cells
VY Chung, TZ Tan, J Ye, RL Huang, HC Lai, D Kappei, H Wollmann, ...
Communications biology 2 (1), 272, 2019
Idiopathic low ovarian reserve is associated with more frequent positive thyroid peroxidase antibodies
CW Chen, YL Huang, CR Tzeng, RL Huang, CH Chen
Thyroid 27 (9), 1194-1200, 2017
Genome-wide DNA methylation analysis reveals estrogen-mediated epigenetic repression of metallothionein-1 gene cluster in breast cancer
RR Jadhav, Z Ye, RL Huang, J Liu, PY Hsu, YW Huang, LB Rangel, ...
Clinical epigenetics 7, 1-15, 2015
Global methylation silencing of clustered proto‐cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV
KH Wang, CJ Lin, CJ Liu, DW Liu, RL Huang, DC Ding, CF Weng, TY Chu
Cancer medicine 4 (1), 43-55, 2015
Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer
TK Chao, TS Huang, YP Liao, RL Huang, PH Su, HY Shen, HC Lai, ...
PloS one 12 (7), e0182166, 2017
The system can't perform the operation now. Try again later.
Articles 1–20